# Insulin Glulisine, Diabetes Mellitus Type 1

> **NCT00397553** · PHASE3 · COMPLETED · sponsor: **Sanofi** · enrollment: 104 (actual)

## Conditions studied

- Diabetes Mellitus, Type 1

## Interventions

- **DRUG:** Insulin glulisine

## Key facts

- **NCT ID:** NCT00397553
- **Lead sponsor:** Sanofi
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2005-01
- **Primary completion:** 2007-12
- **Final completion:** —
- **Target enrollment:** 104 (ACTUAL)
- **Last updated:** 2009-09-18


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00397553

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00397553, "Insulin Glulisine, Diabetes Mellitus Type 1". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT00397553. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*